Indeed, GM-CSF has been reported to support tumor growth and progression by autocrine stimulation of proliferation and migration in squamous cell carcinoma of skin or head and neck16, 17, gliomas18 and osteosarcoma19. The gene discussed is CSF2; the disease is neoplasm.